Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001567619-22-009494)

Filing Details

Accession Number:: 0001567619-22-009494
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-05-04 12:01:01
Reporting Period:: 2022-04-29

Accepted Time:: 2022-05-04 12:01:01
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1048477	Biomarin Pharmaceutical Inc	BMRN	Pharmaceutical Preparations (2834)	680397820

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1380710	Eric George Davis	C/O Biomarin Pharmaceutical Inc. 770 Lindaro St. San Rafael CA 94901	Evp, Chief Legal Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-04-29	341	$62.41	66,339	No	5	A	Direct
Common Stock	Acquisiton	2022-05-02	15,347	$37.46	81,686	No	4	M	Direct
Common Stock	Disposition	2022-05-02	15,347	$80.38	66,339	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	5	A	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to buy Common Stock)	Disposition	2022-05-02	15,347	$0.00	15,347	$37.46

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2012-11-08	2022-05-07	No	4	M	Direct

Footnotes

Represents shares acquired by the reporting person on April 29, 2022, pursuant to the issuer's Employee Stock Purchase Plan.
Trade made pursuant to a 10b5-1 plan executed on March 4, 2022.
Reflects the number of options outstanding after the transactions from this specific stock option grant.